Mon, Apr 14, 2025 | Updated 03:38 IST
Covishield will get EMA approval in a month, says Adar Poonawala at Indian Global Forum 2021
Jun 30, 2021
New Delhi [India], June 30 : Serum Institute of India is confident of receiving approval from the European Medicines Agency (EMA) for its COVID-19...
Zydus receives final approval from USFDA to market Colestipol Hydrochloride tablets
Mar 14, 2022
Ahmedabad (Gujarat) [India], March 15 : Zydus Lifesciences Ltd. has received final approval from the United States Food and Drug Administration (USFDA) to market...
DCGI gives market approval for Pneumococcal Polysaccharide Conjugate Vaccine
Jul 15, 2020
New Delhi [India], July 15 : The Drug Controller General of India (DCGI) has given approval to the first fully indigenously developed Pneumococcal Polysaccharide...
Serum Institute seeks DCGI nod for clinical trials of COVID-19 vaccine COVOVAX
Jan 30, 2021
New Delhi [India], January 30 : Pharma giant Serum Institute of India (SII), whose Covishield vaccine has already received restricted emergency use approval by...
DCGI gives nod to Serum Institute to hold Phase II, III COVID vaccine trials
Aug 03, 2020
New Delhi [India], Aug 3 : The The Drugs Controller General of India (DCGI) gave approval to Serum Institute of India, Pune to conduct...
Zydus receives final approval from USFDA to market drug used to relieve chest pain
Mar 09, 2022
New Delhi [India], March 9 : Zydus Lifesciences Ltd. has received final approval from the United States Food and Drug Administration (USFDA) to market...
Bharat Biotech gets SEC approval for phase 3 clinical trials of COVID booster intranasal vaccine
Jan 05, 2022
Bikaji Foods files draft papers with SEBI for IPO
Feb 23, 2022
SK Bioscience suspends production of COVID-19 vaccine 'Sky Covione'
Nov 24, 2022
DCGI recommends Covovax as heterologous booster dose
Jan 12, 2023
DCGI's subject expert committee to hold discussion on 'Five Arms' intranasal heterologous booster dose on Nov 15, sources
Nov 12, 2022
Biocon Biologics gets U.S. FDA approval for biosimilar aflibercept Yesafili, enters US ophthalmology market
May 21, 2024
Related Videos
No Result Found